Tarsus Pharmaceuticals, Inc. - stock earnings
TARS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -41.9 million USD | 13.1 million USD |
| 2023Q3 | -39.1 million USD | 1.9 million USD |
| 2023Q2 | -31.4 million USD | 15.3 million USD |
| 2023Q1 | -21.9 million USD | 2.5 million USD |
| 2022Q4 | -13.1 million USD | 10.0 million USD |
| 2022Q3 | -22.5 million USD | ? USD |
| 2022Q2 | -6.3 million USD | 15.3 million USD |
| 2022Q1 | -20.2 million USD | 539000 USD |
| 2021Q4 | -14.9 million USD | 338000 USD |
| 2021Q3 | -15.7 million USD | 1.2 million USD |
| 2021Q2 | 6.3 million USD | 22.0 million USD |
| 2021Q1 | 10.4 million USD | 33.4 million USD |
| 2020Q4 | -11.5 million USD | ? USD |
| 2020Q3 | -10.1 million USD | ? USD |
| 2020Q2 | -3.3 million USD | ? USD |
| 2020Q1 | -2.0 million USD | ? USD |
| 2019Q4 | -1.4 million USD | ? USD |
| 2019Q3 | -681000 USD | ? USD |
| 2019Q2 | -1.2 million USD | ? USD |
| 2019Q1 | -1.2 million USD | ? USD |
| 2018Q4 | -1.2 million USD | ? USD |
| 2018Q2 | -329750 USD | ? USD |
| 2018Q1 | -329750 USD | ? USD |
| 2017Q4 | -329750 USD | ? USD |
TARS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -135.9 million USD | 17.4 million USD |
| 2022 | -62.1 million USD | 25.8 million USD |
| 2021 | -13.8 million USD | 57.0 million USD |
| 2020 | -26.8 million USD | 33.4 million USD |
| 2019 | -4.7 million USD | ? USD |
| 2018 | -1.3 million USD | ? USD |
TARS
Price: $32.37
52 week price:
Earnings Per Share: -4.62 USD
P/E Ratio: -7.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 37491
Market Capitalization: 1.3 billion